Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - Eloxx Pharmaceuticals, Inc. | v238087_ex99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): October 26, 2011
Senesco Technologies, Inc.
(Exact Name of Registrant as Specified in Charter)
|
Delaware
|
001-31326
|
84-1368850
|
|
(State or Other Jurisdiction
of Incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
721 Route 202/206, Suite 130, Bridgewater, NJ
|
08807
|
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
|
(908) 864-4444
|
|
(Registrant's telephone number,
including area code)
|
|
Not applicable
(Former Name or Former Address, if Changed Since Last Report)
|
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).
|
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).
|
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).
|
|
Item 8.01
|
Other Events.
|
On October 26, 2011, Senesco Technologies, Inc. (the “Company”) issued a press release providing an update regarding the following: the Company’s open Phase 1b/2a clinical study for SNS01-T in multiple myeloma; the Company’s agricultural applications; the Company’s corporate goals and objectives for Fiscal 2012; the Company’s current financial condition; and the Company’s status as a listed company on the NYSE Amex LLC.
A copy of the press release is filed herewith as Exhibit 99.1.
|
Item 9.01
|
Financial Statements and Exhibits.
|
(d) Exhibits.
|
Exhibit No.
|
Description
|
|
99.1
|
Press Release dated October 26, 2011.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
SENESCO TECHNOLOGIES, INC.
|
|||
|
Dated: October 26, 2011
|
By:
|
/s/ Leslie J. Browne, Ph.D. | |
|
Name: Leslie J. Browne, Ph.D.
|
|||
|
Title: President and Chief Executive Officer
|
|||